Osaic Holdings’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.38K | Sell |
1,012
-988
| -49% | -$4.27K | ﹤0.01% | 6199 |
|
2025
Q1 | $6.28K | Buy |
2,000
+561
| +39% | +$1.76K | ﹤0.01% | 5979 |
|
2024
Q4 | $6.25K | Buy |
1,439
+39
| +3% | +$169 | ﹤0.01% | 5982 |
|
2024
Q3 | $3.74K | Hold |
1,400
| – | – | ﹤0.01% | 6209 |
|
2024
Q2 | $3.11K | Sell |
1,400
-440
| -24% | -$977 | ﹤0.01% | 6268 |
|
2024
Q1 | $9.83K | Hold |
1,840
| – | – | ﹤0.01% | 5679 |
|
2023
Q4 | $2.72K | Buy |
1,840
+1,000
| +119% | +$1.48K | ﹤0.01% | 6305 |
|
2023
Q3 | $1.17K | Sell |
840
-725
| -46% | -$1.01K | ﹤0.01% | 6638 |
|
2023
Q2 | $2.3K | Hold |
1,565
| – | – | ﹤0.01% | 6506 |
|
2023
Q1 | $2.58K | Buy |
1,565
+284
| +22% | +$469 | ﹤0.01% | 6513 |
|
2022
Q4 | $2K | Sell |
1,281
-131
| -9% | -$205 | ﹤0.01% | 6573 |
|
2022
Q3 | $3K | Sell |
1,412
-265
| -16% | -$563 | ﹤0.01% | 6537 |
|
2022
Q2 | $4K | Sell |
1,677
-531
| -24% | -$1.27K | ﹤0.01% | 6531 |
|
2022
Q1 | $5K | Sell |
2,208
-1,166
| -35% | -$2.64K | ﹤0.01% | 6393 |
|
2021
Q4 | $20K | Buy |
3,374
+900
| +36% | +$5.34K | ﹤0.01% | 5754 |
|
2021
Q3 | $17K | Sell |
2,474
-119
| -5% | -$818 | ﹤0.01% | 5861 |
|
2021
Q2 | $18K | Sell |
2,593
-10,956
| -81% | -$76.1K | ﹤0.01% | 5701 |
|
2021
Q1 | $125K | Buy |
13,549
+11,358
| +518% | +$105K | ﹤0.01% | 4169 |
|
2020
Q4 | $39K | Sell |
2,191
-1,309
| -37% | -$23.3K | ﹤0.01% | 4715 |
|
2020
Q3 | $50K | Buy |
+3,500
| New | +$50K | ﹤0.01% | 4283 |
|